Literature DB >> 31322055

Patient and Health Care Provider Needs and Preferences in Understanding Pharmacogenomic and Genomic Testing: A Meta-Data Analysis.

Sophie Veilleux1, Maud Bouffard1, Mijanou Bourque Bouliane1.   

Abstract

Tests that feature genomic indicators can now be used to guide the pharmacological treatment of patients. To better identify the needs and preferences of patients and health care providers in facilitating their understanding of information related to such pharmacogenomic tests (PGx), a review of literature on knowledge translation and health literacy in the context of testing was conducted. Using a grounded theory-based approach, a comparative analysis of data from 36 studies meeting the criteria for the meta-data analysis has revealed the recurrence of three principal themes: (a) knowledge and understanding of genetics and pharmacogenomics; (b) experiences with genetic, genomic, or PGx testing (decision about the test, information delivery, and understanding of test results); and (c) educational/informational resources. This synthesis sheds light on each theme from the standpoint of both patients and health care providers and suggests avenues in which to direct efforts to support the introduction of pharmacogenomic tests in current practice.

Entities:  

Keywords:  health literacy; knowledge translation; meta-data analysis; pharmacogenomic testing; qualitative

Year:  2019        PMID: 31322055     DOI: 10.1177/1049732319858325

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  6 in total

Review 1.  Strategic vision for improving human health at The Forefront of Genomics.

Authors:  Eric D Green; Chris Gunter; Leslie G Biesecker; Valentina Di Francesco; Carla L Easter; Elise A Feingold; Adam L Felsenfeld; David J Kaufman; Elaine A Ostrander; William J Pavan; Adam M Phillippy; Anastasia L Wise; Jyoti Gupta Dayal; Britny J Kish; Allison Mandich; Christopher R Wellington; Kris A Wetterstrand; Sarah A Bates; Darryl Leja; Susan Vasquez; William A Gahl; Bettie J Graham; Daniel L Kastner; Paul Liu; Laura Lyman Rodriguez; Benjamin D Solomon; Vence L Bonham; Lawrence C Brody; Carolyn M Hutter; Teri A Manolio
Journal:  Nature       Date:  2020-10-28       Impact factor: 49.962

2.  Preferences for and acceptability of receiving pharmacogenomic results by mail: A focus group study with a primarily African-American cohort.

Authors:  Priscilla A Chan; Katie L Lewis; Barbara B Biesecker; Lori H Erby; Grace-Ann Fasaye; Sandra Epps; Leslie G Biesecker; Erin Turbitt
Journal:  J Genet Couns       Date:  2021-04-19       Impact factor: 2.717

3.  Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations.

Authors:  Chad A Bousman; Patrick Wu; Katherine J Aitchison; Tony Cheng
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

4.  Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life.

Authors:  Lauren Kelada; Claire Wakefield; Nada Vidic; David S Armstrong; Bruce Bennetts; Kirsten Boggs; John Christodoulou; Joanne Harrison; Gladys Ho; Nitin Kapur; Suzanna Lindsey-Temple; Tim McDonald; David Mowat; André Schultz; Hiran Selvadurai; Andrew Tai; Adam Jaffe
Journal:  BMJ Open Respir Res       Date:  2022-02

5.  Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?

Authors:  Karen M Meagher; Kelsey Stuttgen Finn; Susan H Curtis; Jack Borucki; Annika T Beck; Amal W Cheema; Richard R Sharp
Journal:  Clin Transl Sci       Date:  2021-11-25       Impact factor: 4.689

6.  Pharmacogenomic alerts: Developing guidance for use by healthcare professionals.

Authors:  John-Paul L Carter; James Critchlow; Sarah Jackson; Sonali Sanghvi; Helene Feger; Afzal Chaudhry; Lorraine Foley; Reecha Sofat
Journal:  Br J Clin Pharmacol       Date:  2022-02-14       Impact factor: 3.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.